Your browser doesn't support javascript.
loading
Contemporary rates and predictors of open conversion during minimally invasive partial nephrectomy for kidney cancer.
Luzzago, Stefano; Rosiello, Giuseppe; Pecoraro, Angela; Deuker, Marina; Stolzenbach, Franziska; Mistretta, Francesco Alessandro; Tian, Zhe; Musi, Gennaro; Montanari, Emanuele; Shariat, Shahrokh F; Saad, Fred; Briganti, Alberto; de Cobelli, Ottavio; Karakiewicz, Pierre I.
Afiliação
  • Luzzago S; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, European Institute of Oncology, IRCCS, Milan, Italy. Electronic address: stefanoluzzago@gmail.com.
  • Rosiello G; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Pecoraro A; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, San Luigi Gonzaga Hospital, University of Turin, Turin, Italy.
  • Deuker M; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, University Hospital Frankfurt, Frankfurt Am Main, Germany.
  • Stolzenbach F; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Martini Klinik, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Mistretta FA; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; Department of Urology, European Institute of Oncology, IRCCS, Milan, Italy.
  • Tian Z; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada.
  • Musi G; Department of Urology, European Institute of Oncology, IRCCS, Milan, Italy.
  • Montanari E; Department of Urology, IRCCS Fondazione Ca' Granda-Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.
  • Shariat SF; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Department of Urology, Weill Cornell Medical College, New York, NY, USA; Department of Urology, University of Texas Southwestern, Dallas, TX, USA; Department of Urology, Second Faculty of Medicine, Cha
  • Saad F; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada.
  • Briganti A; Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • de Cobelli O; Department of Urology, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  • Karakiewicz PI; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada.
Surg Oncol ; 36: 131-137, 2021 Mar.
Article em En | MEDLINE | ID: mdl-33401103
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Robótica / Carcinoma de Células Renais / Laparoscopia / Procedimentos Cirúrgicos Minimamente Invasivos / Conversão para Cirurgia Aberta / Neoplasias Renais / Nefrectomia Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Robótica / Carcinoma de Células Renais / Laparoscopia / Procedimentos Cirúrgicos Minimamente Invasivos / Conversão para Cirurgia Aberta / Neoplasias Renais / Nefrectomia Idioma: En Ano de publicação: 2021 Tipo de documento: Article